FOXP3 and synovial sarcoma: Mucosal administration of α-fodrin effectively suppresses the production of SS-related antibodies, prevents the in vivo production of inflammatory cytokines, such as IFNγ, and increases the number of Foxp3+ CD4+CD25+ regulatory T cells.